176 studies found for:    Encephalitis
Show Display Options
Rank Status Study
21 Completed
Has Results
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine;   Biological: Japanese encephalitis vaccine (Acambis);   Biological: Hepatitis A vaccine
22 Completed Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
Condition: Japanese Encephalitis
Interventions: Biological: Mouse brain derived japanese encephalitis vaccine (MB-JEV);   Biological: Primary and booster immunizations with MB-JEV;   Biological: C) primary immunizations with Ixiaro;   Biological: S) Ixiaro booster to MBJEV primed
23 Completed
Has Results
Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country
Condition: Japanese Encephalitis
Intervention: Biological: IXIARO
24 Completed Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
25 Completed An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
Condition: Tick Borne Encephalitis (TBE)
Intervention: Other: Serology blood draw
26 Completed A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
Conditions: Chronic Focal Encephalitis;   Rasmussen's Encephalitis
Intervention: Drug: Rituximab
27 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
28 Withdrawn Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
Condition: Venezuelan Equine Encephalitis
Intervention: Biological: VEE 3526
29 Completed
Has Results
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
30 Completed Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
Condition: Venezuelan Equine Encephalitis Virus Infection
Interventions: Biological: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate;   Other: 0.9% saline placebo
31 Completed
Has Results
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
32 Completed
Has Results
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: Japanese Encephalitis purified inactivated vaccine (IC51);   Biological: Placebo
33 Recruiting Tick-borne Encephalitis and Positive Borrelial Antibodies
Condition: Tick-borne Encephalitis
Interventions: Drug: Doxycycline;   Drug: Symptomatic therapy;   Other: Questionnaire
34 Completed
Has Results
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
35 Completed
Has Results
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX
36 Completed
Has Results
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
37 Completed
Has Results
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
38 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
39 Active, not recruiting Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
40 Completed
Has Results
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years